Company Filing History:
Years Active: 2013
Title: Michael V. Pishklo: Innovator in Glucose Monitoring Technology
Introduction: Michael V. Pishklo, based in Austin, Texas, is a notable inventor recognized for his contributions to the field of glucose monitoring technology. With one patent to his name, Pishklo has made significant advancements in the development of innovative medical devices.
Latest Patents: Michael V. Pishklo's patent focuses on a subcutaneous glucose electrode. This small diameter flexible electrode is designed for in vivo amperometric monitoring of glucose levels. The unique feature of this electrode is its capability for 'one-point' in vivo calibration, which allows it to maintain zero output current at zero glucose concentration, even amidst other electroreactive substances found in serum or blood. The design includes multiple layers: the first layer transduces glucose concentration to current, followed by an insulating glucose flux limiting layer, optionally topped with a horseradish peroxidase film to eliminate interference. The entire assembly is encased with a biocompatible outer layer, ensuring its suitability for medical use.
Career Highlights: Michael V. Pishklo is affiliated with Abbott Diabetes Care Inc., a reputable company that focuses on diabetes management solutions. His work at Abbott has contributed to innovations that improve patient care and monitoring efficiency in glucose management.
Collaborations: Throughout his career, Pishklo has collaborated with other talented professionals in the field, including Adam Heller. Their collaborative efforts have fostered advancements in medical device technology, particularly in glucose monitoring.
Conclusion: Michael V. Pishklo exemplifies the spirit of innovation in the medical device industry. His patent for the subcutaneous glucose electrode marks a significant contribution to diabetes care, showcasing his commitment to improving patient outcomes through technological advancements. Through his work at Abbott Diabetes Care Inc., Pishklo continues to influence the landscape of glucose monitoring and management.